OrbiMed Advisors Disposes $22.9M in Sionna Therapeutics Shares Over Three Days
OrbiMed Advisors LLC, acting as a director of Sionna Therapeutics Inc (NASDAQ: SION), sold a total of 510,783 shares in three transactions between April 14 and April 16, 2026, generating $22,945,043 in proceeds. After the trades, the OrbiMed-related vehicle retains an indirect stake of 3,020,119 shares. The divestitures were carried out under a 10b…